1,371
Views
15
CrossRef citations to date
0
Altmetric
Review Articles

Targeted antibiotic discovery through biosynthesis-associated resistance determinants: target directed genome mining

ORCID Icon, , &
Pages 255-277 | Received 04 Jan 2019, Accepted 21 Feb 2019, Published online: 15 Apr 2019

References

  • Agarwal V, Nair SK. 2012. Aminoacyl tRNA synthetases as targets for antibiotic development. MedChemComm. 3:887–898.
  • Aguilera S, López-López K, Nieto Y, Garcidueñas-Piña R, Hernández-Guzmán G, Hernández-Flores JL, Murillo J, Alvarez-Morales A. 2007. Functional characterization of the gene cluster from Pseudomonas syringae pv. phaseolicola NPS3121 involved in synthesis of phaseolotoxin. J Bacteriol. 189:2834–2843.
  • Ahlert J, Shepard E, Lomovskaya N, Zazopoulos E, Staffa A, Bachmann BO, Huang K, Fonstein L, Czisny A, Whitwam RE. 2002. The calicheamicin gene cluster and its iterative type I enediyne PKS. Science. 297:1173–1176.
  • Alanjary M, Kronmiller B, Adamek M, Blin K, Weber T, Huson D, Philmus B, Ziemert N. 2017. The Antibiotic Resistant Target Seeker (ARTS), an exploration engine for antibiotic cluster prioritization and novel drug target discovery. Nucleic Acids Res. 45:W42–W48.
  • Almutairi MM, Park SR, Rose S, Hansen DA, Vazquez-Laslop N, Douthwaite S, Sherman DH, Mankin AS. 2015. Resistance to ketolide antibiotics by coordinated expression of rRNA methyltransferases in a bacterial producer of natural ketolides. Proc Natl Acad Sci U S A. 112:12956–12961.
  • Andersson DI, Levin BR. 1999. The biological cost of antibiotic resistance. Curr Opin Microbiol. 2:489–493.
  • Armstrong RW, Salvati ME, Nguyen M. 1992. Novel interstrand cross-links induced by the antitumor antibiotic carzinophilin/azinomycin B. J Am Chem Soc. 114:3144–3145.
  • Arthur M, Molinas C, Depardieu F, Courvalin P. 1993. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol. 175:117–127.
  • Azumi M, Ishidoh K, Kinoshita H, Nihira T, Ihara F, Fujita T, Igarashi Y. 2008. Aurovertins F-H from the entomopathogenic fungus Metarhizium anisopliae. J Nat Prod. 71:278–280.
  • Bagley MC, Dale JW, Merritt EA, Xiong X. 2005. Thiopeptide antibiotics. Chem Rev. 105:685–714.
  • Ballesta JP, Cundliffe E. 1991. Site-specific methylation of 16S rRNA caused by pct, a pactamycin resistance determinant from the producing organism, Streptomyces pactum. J Bacteriol. 173:7213–7218.
  • Barna JC, Williams DH. 1984. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol. 38:339–357.
  • Baumann S, Herrmann J, Raju R, Steinmetz H, Mohr KI, Huttel S, Harmrolfs K, Stadler M, Muller R. 2014. Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activity. Angew Chem Int Ed. 53:14605–14609.
  • Beauclerk AA, Cundliffe E. 1987. Sites of action of two ribosomal RNA methylases responsible for resistance to aminoglycosides. J Mol Biol. 193:661–671.
  • Bentley R. 2000. Mycophenolic acid: a one hundred year odyssey from antibiotic to immunosuppressant. Chem Rev. 100:3801–3826.
  • Bergmann S, Funk AN, Scherlach K, Schroeckh V, Shelest E, Horn U, Hertweck C, Brakhage AA. 2010. Activation of a silent fungal polyketide biosynthesis pathway through regulatory cross talk with a cryptic nonribosomal peptide synthetase gene cluster. Appl Environ Microbiol. 76:8143–8149.
  • Bhuyan BK, Owen SP, Dietz A. 1964. Rubradirin, a new antibiotic. I. Fermentation and biological properties. Antimicrob Agents Chemother (Bethesda). 10:91–96.
  • Biggins JB, Onwueme KC, Thorson JS. 2003. Resistance to enediyne antitumor antibiotics by CalC self-sacrifice. Science. 301:1537–1541.
  • Bochtler M, Ditzel L, Groll M, Hartmann C, Huber R. 1999. The proteasome. Annu Rev Biophys Biomol Struct. 28:295–317.
  • Bonsch B, Belt V, Bartel C, Duensing N, Koziol M, Lazarus CM, Bailey AM, Simpson TJ, Cox RJ. 2016. Identification of genes encoding squalestatin S1 biosynthesis and in vitro production of new squalestatin analogues. Chem Commun (Camb). 52:6777–6780.
  • Bossuet-Greif N, Dubois D, Petit C, Tronnet S, Martin P, Bonnet R, Oswald E, Nougayrede JP. 2016. Escherichia coli ClbS is a colibactin resistance protein. Mol Microbiol. 99:897–908.
  • Brinster S, Lamberet G, Staels B, Trieu-Cuot P, Gruss A, Poyart C. 2009. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature. 458:83–86.
  • Broenstrup M, Koenig C, Toti L, Wink J, Leuschner W, Gassenhuber J, Müller R, Wenzel S, Binz T, Volz C, inventors; Sanofi, assignee. 2013. Gene cluster for biosynthesis of griselimycin and methylgriselimycin.
  • Bushley KE, Raja R, Jaiswal P, Cumbie JS, Nonogaki M, Boyd AE, Owensby CA, Knaus BJ, Elser J, Miller D. 2013. The genome of Tolypocladium inflatum: evolution, organization, and expression of the cyclosporin biosynthetic gene cluster. PLoS Genet. 9:e1003496.
  • Calcutt MJ, Cundliffe E. 1990. Cloning of a lincosamide resistance determinant from Streptomyces caelestis, the producer of celesticetin, and characterization of the resistance mechanism. J Bacteriol. 172:4710–4714.
  • Chamilos G, Lewis RE, Kontoyiannis DP. 2006. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother. 50:96–103.
  • Cheigh CI, Pyun YR. 2005. Nisin biosynthesis and its properties. Biotechnol Lett. 27:1641–1648.
  • Chen L, Li P, Deng Z, Zhao C. 2015. Ornithine transcarbamylase ArgK plays a dual role for the self-defense of phaseolotoxin producing Pseudomonas syringae pv. phaseolicola. Sci Rep. 5:12892.
  • Chopra I, Roberts M. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 65:232–260.
  • Cochrane RVK, Sanichar R, Lambkin GR, Reiz B, Xu W, Tang Y, Vederas JC. 2016. Production of new cladosporin analogues by reconstitution of the polyketide synthases responsible for the biosynthesis of this antimalarial agent. Angew Chem. 128:674–678.
  • Cociancich S, Pesic A, Petras D, Uhlmann S, Kretz J, Schubert V, Vieweg L, Duplan S, Marguerettaz M, Noell J, et al. 2015. The gyrase inhibitor albicidin consists of p-aminobenzoic acids and cyanoalanine. Nat Chem Biol. 11:195–197.
  • Connell SR, Tracz DM, Nierhaus KH, Taylor DE. 2003. Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob Agents Chemother. 47:3675–3681.
  • Coque JJR, Liras P, Martin JF. 1993. Genes for a beta-lactamase, a penicillin-binding protein and a transmembrane protein are clustered with the cephamycin biosynthetic genes in Nocardia lactamdurans. Embo J. 12:631–639.
  • Cundliffe E. 1992. Resistance to macrolides and lincosamides in Streptomyces lividans and to aminoglycosides in Micromonospora purpurea. Gene. 115:75–84.
  • Cundliffe E, Thompson J. 1981. The mode of action of nosiheptide (multhiomycin) and the mechanism of resistance in the producing organism. J Gen Microbiol. 126:185–192.
  • Dagnolo G, Rosenfel I, Awaya J, Omura S, Vagelos PR. 1973. Inhibition of fatty-acid synthesis by antibiotic cerulenin - specific inactivation of beta-ketoacyl-acyl carrier protein synthetase. Biochim Biophys Acta. 326:155–166.
  • Davies J, Davies D. 2010. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 74:417–433.
  • Dawson MJ, Farthing JE, Marshall PS, Middleton RF, O'Neill MJ, Shuttleworth A, Stylli C, Tait RM, Taylor PM, Wildman HG. 1992. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. J Antibiot. 45:639–647.
  • D'Costa VM, McGrann KM, Hughes DW, Wright GD. 2006. Sampling the antibiotic resistome. Science. 311:374–377.
  • Dhillon N, Hale RS, Cortes J, Leadlay PF. 1989. Molecular characterization of a gene from Saccharopolyspora erythraea (Streptomyces erythraeus) which is involved in erythromycin biosynthesis. Mol Microbiol. 3:1405–1414.
  • Du YL, Alkhalaf LM, Ryan KS. 2015. In vitro reconstitution of indolmycin biosynthesis reveals the molecular basis of oxazolinone assembly. Proc Natl Acad Sci U S A. 112:2717–2722.
  • El-Sayed AK, Hothersall J, Cooper SM, Stephens E, Simpson TJ, Thomas CM. 2003. Characterization of the mupirocin biosynthesis gene cluster from Pseudomonas fluorescens NCIMB 10586. Chem Biol. 10:419–430.
  • Elshahawi SI, Ramelot TA, Seetharaman J, Chen J, Singh S, Yang Y, Pederson K, Kharel MK, Xiao R, Lew S, et al. 2014. Structure-guided functional characterization of enediyne self-sacrifice resistance proteins, CalU16 and CalU19. ACS Chem Biol. 9:2347–2358.
  • Eustaquio AS, Li SM, Heide L. 2005. NovG, a DNA-binding protein acting as a positive regulator of novobiocin biosynthesis. Microbiology. 151:1949–1961.
  • Eustaquio AS, McGlinchey RP, Liu Y, Hazzard C, Beer LL, Florova G, Alhamadsheh MM, Lechner A, Kale AJ, Kobayashi Y, et al. 2009. Biosynthesis of the salinosporamide A polyketide synthase substrate chloroethylmalonyl-coenzyme A from S-adenosyl-L-methionine. Proc Natl Acad Sci U S A. 106:12295–12300.
  • Feling RH, Buchanan GO, Mincer TJ, Kauffman CA, Jensen PR, Fenical W. 2003. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora. Angew Chem Int Ed. 42:355–357.
  • Ferguson AR, Johnston JS. 1980. Phaseolotoxin - chlorosis, ornithine accumulation and inhibition of ornithine carbamoyltransferase in different plants. Physiological Plant Pathology. 16:269–275.
  • Flinspach K, Kapitzke C, Tocchetti A, Sosio M, Apel AK. 2014. Heterologous expression of the thiopeptide antibiotic GE2270 from Planobispora rosea ATCC 53733 in Streptomyces coelicolor requires deletion of ribosomal genes from the expression construct. PLoS One. 9:e90499.
  • Floss HG, Yu TW. 2005. Rifamycin-mode of action, resistance, and biosynthesis. Chem Rev. 105:621–632.
  • Fredenhagen A, Tamura SY, Kenny PTM, Komura H, Naya Y, Nakanishi K, Nishiyama K, Sugiura M, Kita H. 1987. Andrimid, a new peptide antibiotic produced by an intracellular bacterial symbiont isolated from a brown planthopper. J Am Chem Soc. 109:4409–4411.
  • Freel KC, Millán-Aguiñaga N, Jensen PR. 2013. Multilocus sequence typing reveals evidence of homologous recombination linked to antibiotic resistance in the genus Salinispora. Appl Environ Microbiol. 79:5997–6005.
  • Freiberg C, Brunner NA, Schiffer G, Lampe T, Pohlmann J, Brands M, Raabe M, Habich D, Ziegelbauer K. 2004. Identification and characterization of the first class of potent bacterial acetyl-CoA carboxylase inhibitors with antibacterial activity. J Biol Chem. 279:26066–26073.
  • Frisvad JC, Smedsgaard J, Larsen TO, Samson RA. 2004. Mycotoxins, drugs and other extrolites produced by species in Penicillium subgenus Penicillium. Stud Mycol. 49:201–241.
  • Fukuda D, Haines AS, Song Z, Murphy AC, Hothersall J, Stephens ER, Gurney R, Cox RJ, Crosby J, Willis CL, et al. 2011. A natural plasmid uniquely encodes two biosynthetic pathways creating a potent anti-MRSA antibiotic. Plos One. 6.
  • Garg RP, Qian XL, Alemany LB, Moran S, Parry RJ. 2008. Investigations of valanimycin biosynthesis: elucidation of the role of seryl-tRNA. Proc Natl Acad Sci U S A. 105:6543–6547.
  • Gause EM, Buck MA, Douglas MG. 1981. Binding of citreoviridin to the beta subunit of the yeast F1-ATPase. J Biol Chem. 256:557–559.
  • Gebauer F, Hentze MW. 2004. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol. 5:827–835.
  • Ghuysen JM. 1991. Serine beta-lactamases and penicillin-binding proteins. Annu Rev Microbiol. 45:37–67.
  • Gubaev A, Klostermeier D. 2014. The mechanism of negative DNA supercoiling: a cascade of DNA-induced conformational changes prepares gyrase for strand passage. DNA Repair (Amst). 16:23–34.
  • Gupta P, Sothiselvam S, Vázquez-Laslop N, Mankin AS. 2013. Deregulation of translation due to post-transcriptional modification of rRNA explains why erm genes are inducible. Nat Commun. 4.
  • Ha KR, Psaltis AJ, Butcher AR, Wormald PJ, Tan LW. 2008. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope. 118:535–540.
  • Hanada M, Sugawara K, Kaneta K, Toda S, Nishiyama Y, Tomita K, Yamamoto H, Konishi M, Oki T. 1992. Epoxomicin, a new antitumor agent of microbial origin. J Antibiot. 45:1746–1752.
  • Hansen BG, Genee HJ, Kaas CS, Nielsen JB, Regueira TB, Mortensen UH, Frisvad JC, Patil KR. 2011. A new class of IMP dehydrogenase with a role in self-resistance of mycophenolic acid producing fungi. BMC Microbiol. 11:202.
  • Harms JM, Wilson DN, Schluenzen F, Connell SR, Stachelhaus T, Zaborowska Z, Spahn CMT, Fucini P. 2008. Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin. Molecular Cell. 30:26–38.
  • Hayashi T, Yamamoto O, Sasaki H, Kawaguchi A, Okazaki H. 1983. Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli . Biochem Biophys Res Commun. 115:1108–1113.
  • Heath RJ, Rock CO. 2004. Fatty acid biosynthesis as a target for novel antibacterials. Curr Opin Investig Drugs. 5:146–153.
  • Heath RJ, Rubin JR, Holland DR, Zhang E, Snow ME, Rock CO. 1999. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem. 274:11110–11114.
  • Hedstrom L. 2009. IMP dehydrogenase: structure, mechanism, and inhibition. Chem Rev. 109:2903–2928.
  • Hegde SS, Vetting MW, Roderick SL, Mitchenall LA, Maxwell A, Takiff HE, Blanchard JS. 2005. A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. Science. 308:1480–1483.
  • Heide L. 2009. The aminocoumarins: biosynthesis and biology. Nat Prod Rep. 26:1241–1250.
  • Heide L. 2014. New aminocoumarin antibiotics as gyrase inhibitors. Int J Med Microbiol. 304:31–36.
  • Helmkamp GM, Rando RR, Brock DJH, Bloch K. 1968. β-Hydroxydecanoyl thioester dehydrase: specificity of substrates and acetylenic inhibitors. J Biol Chem. 243:3229–3231.
  • Herath KB, Attygalle AB, Singh SB. 2007. Biosynthetic studies of platensimycin. J Am Chem Soc. 129:15422–15423.
  • Hoeksema H, Mizsak SA, Baczynskyj L. 1979. The chemistry of rubradirin. III. The rubradiric acids and the structure of rubradirin. J Antibiot. 32:773–776.
  • Hoepfner D, McNamara CW, Lim CS, Studer C, Riedl R, Aust T, McCormack SL, Plouffe DM, Meister S, Schuierer S, et al. 2012. Selective and specific inhibition of the Plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin. Cell Host Microbe. 11:654–663.
  • Horna DH, Gomez C, Olano C, Palomino-Schatzlein M, Pineda-Lucena A, Carbajo RJ, Brana AF, Mendez C, Salas JA. 2011. Biosynthesis of the RNA polymerase inhibitor streptolydigin in Streptomyces lydicus: tailoring modification of 3-methyl-aspartate. J Bacteriol. 193:2647–2651.
  • Huang W, Xu H, Li Y, Zhang F, Chen XY, He QL, Igarashi Y, Tang GL. 2012. Characterization of yatakemycin gene cluster revealing a radical S-adenosylmethionine dependent methyltransferase and highlighting spirocyclopropane biosynthesis. J Am Chem Soc. 134:8831–8840.
  • Hughes J, Mellows G. 1978. Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J. 176:305–318.
  • Hutchinson CR, Kennedy J, Park C, Kendrew S, Auclair K, Vederas J. 2000. Aspects of the biosynthesis of non-aromatic fungal polyketides by iterative polyketide synthases. Antonie Van Leeuwenhoek. 78:287–295.
  • Ibba M, Söll D. 2000. Aminoacyl-tRNA synthesis. Annu Rev Biochem. 69:617–650.
  • Igarashi Y, Futamata K, Fujita T, Sekine A, Senda H, Naoki H, Furumai T. 2003. Yatakemycin, a novel antifungal antibiotic produced by Streptomyces sp. TP-A0356. J Antibiot. 56:107–113.
  • Ishiyama A, Iwatsuki M, Namatame M, Nishihara-Tsukashima A, Sunazuka T, Takahashi Y, Ōmura S, Otoguro K. 2011. Borrelidin, a potent antimalarial: stage-specific inhibition profile of synchronized cultures of Plasmodium falciparum. J Antibiot. 64:381–384.
  • Jiang XL, Ellabaan MMH, Charusanti P, Munck C, Blin K, Tong YJ, Weber T, Sommer MOA, Lee SY. 2017. Dissemination of antibiotic resistance genes from antibiotic producers to pathogens. Nat Comms. 8:15784.
  • Jin M, Fischbach MA, Clardy J. 2006. A biosynthetic gene cluster for the acetyl-CoA carboxylase inhibitor andrimid. J Am Chem Soc. 128:10660–10661.
  • Johnston CW, Skinnider MA, Dejong CA, Rees PN, Chen GM, Walker CG, French S, Brown ED, Bérdy J, Liu DY, Magarvey NA. 2016. Assembly and clustering of natural antibiotics guides target identification. Nat Chem Biol. 12:233–239.
  • Juncioni de Arauz L, Jozala AF, Mazzola PG, Penna T. 2009. Nisin biotechnological production and application: a review. Trends Food Sci Technol. 20:146–154.
  • Kale AJ, McGlinchey RP, Lechner A, Moore BS. 2011. Bacterial self-resistance to the natural proteasome inhibitor salinosporamide A. Acs Chem Biol. 6:1257–1264.
  • Kale AJ, Moore BS. 2012. Molecular mechanisms of acquired proteasome inhibitor resistance. J Med Chem. 55:10317–10327.
  • Kamigiri K, Suzuki Y, Shibazaki M, Morioka M, Suzuki K, Tokunaga T, Setiawan B, Rantiatmodjo RM. 1996. Kalimantacins A, B and C, novel antibiotics from Alcaligenes sp YL-02632S.1. Taxonomy, fermentation, isolation and biological properties. J Antibiot. 49:136–139.
  • Kharel MK, Subba B, Basnet DB, Woo JS, Lee HC, Liou K, Sohng JK. 2004. A gene cluster for biosynthesis of kanamycin from Streptomyces kanamyceticus: comparison with gentamicin biosynthetic gene cluster. Arch Biochem Biophys. 429:204–214.
  • Kim TK, Hewavitharana AK, Shaw PN, Fuerst JA. 2006. Discovery of a new source of rifamycin antibiotics in marine sponge actinobacteria by phylogenetic prediction. Appl Environ Microbiol. 72:2118–2125.
  • Kim JG, Park BK, Kim SU, Choi D, Nahm BH, Moon JS, Reader JS, Farrand SK, Hwang I. 2006. Bases of biocontrol: sequence predicts synthesis and mode of action of agrocin 84, the Trojan Horse antibiotic that controls crown gall. Proc Natl Acad Sci U S A. 103:8846–8851.
  • Kim CG, Yu TW, Fryhle CB, Handa S, Floss HG. 1998. 3-Amino-5-hydroxybenzoic acid synthase, the terminal enzyme in the formation of the precursor of mC7N units in rifamycin and related antibiotics. J Biol Chem. 273:6030–6040.
  • Kim CG, Lamichhane J, Song KI, Nguyen VD, Kim DH, Jeong TS, Kang SH, Kim KW, Maharjan J, Hong YS, et al. 2008. Biosynthesis of rubradirin as an ansamycin antibiotic from Streptomyces achromogenes var. rubradiris NRRL3061. Arch Microbiol. 189:463–473.
  • Kling A, Lukat P, Almeida DV, Bauer A, Fontaine E, Sordello S, Zaburannyi N, Herrmann J, Wenzel SC, König C, et al. 2015. Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins. Science. 348:1106–1112.
  • Kumagai T, Hibino R, Kawano Y, Sugiyama M. 1999. Mutation of the N-terminal proline 9 of BLMA from Streptomyces verticillus abolishes the binding affinity for bleomycin. FEBS Lett. 450:227–230.
  • Laiple KJ, Hartner T, Fiedler HP, Wohlleben W, Weber T. 2009. The kirromycin gene cluster of Streptomyces collinus Tü 365 codes for an aspartate-alpha-decarboxylase, KirD, which is involved in the biosynthesis of the precursor beta-alanine . J Antibiot. 62:465–468.
  • Langley DB, Templeton MD, Fields BA, Mitchell RE, Collyer CA. 2000. Mechanism of inactivation of ornithine transcarbamoylase by N δ-(N-sulfodiaminophosphinyl)-L-ornithine, a true transition state analogue?: crystal structure and implications for catalytic mechanism. J Biol Chem. 275:20012–20019.
  • Li XZ, Nikaido H. 2009. Efflux-mediated drug resistance in bacteria: an update. Drugs. 69:1555–1623.
  • Lin TS, Chiang YM, Wang CC. 2016. Biosynthetic pathway of the reduced polyketide product citreoviridin in Aspergillus terreus var. Aureus revealed by heterologous expression in Aspergillus nidulans. Org Lett. 18:1366–1369.
  • Lin HC, Chooi YH, Dhingra S, Xu W, Calvo AM, Tang Y. 2013. The Fumagillin Biosynthetic Gene Cluster in Aspergillus fumigatus Encodes a Cryptic Terpene Cyclase Involved in the Formation of β-trans-Bergamotene. J Am Chem Soc. 135:4616–4619.
  • Liu X, Fortin PD, Walsh CT. 2008. Andrimid producers encode an acetyl-CoA carboxyltransferase subunit resistant to the action of the antibiotic. Proc Natl Acad Sci U S A. 105:13321–13326.
  • Lubelski J, Konings WN, Driessen AJ. 2007. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol Mol Biol Rev. 71:463–476.
  • Manallack DT, Crosby IT, Khakham Y, Capuano B. 2008. Platensimycin: a promising antimicrobial targeting fatty acid synthesis. Curr Med Chem. 15:705–710.
  • Marrakchi H, Lanéelle G, Quémard A. 2000. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology. 146:289–296.
  • Mattheus W, Gao LJ, Herdewijn P, Landuyt B, Verhaegen J, Masschelein J, Volckaert G, Lavigne R. 2010. Isolation and purification of a new kalimantacin/batumin-related polyketide antibiotic and elucidation of its biosynthesis gene cluster. Chem Biol. 17:149–159.
  • Mattheus W, Masschelein J, Gao LJ, Herdewijn P, Landuyt B, Volckaert G, Lavigne R. 2010. The kalimantacin/batumin biosynthesis operon encodes a self-resistance isoform of the FabI bacterial target. Chem Biol. 17:1067–1071.
  • Maxwell A. 1993. The interaction between coumarin drugs and DNA gyrase. Mol Microbiol. 9:681–686.
  • Metlitskaya A, Kazakov T, Kommer A, Pavlova O, Praetorius-Ibba M, Ibba M, Krasheninnikov I, Kolb V, Khmel I, Severinov K. 2006. Aspartyl-tRNA synthetase Is the target of peptide nucleotide antibiotic microcin C. J Biol Chem. 281:18033–18042.
  • Meyer CE, Mason DJ. 1965. New antibiotics produced by Streptomyces caelestis. Antimicrob Agents Chemother (Bethesda). 5:850–854.
  • Mitchell RE. 1976. Isolation and structure of a chlorosis-inducing toxin of Pseudomonas phaseolicola. Phytochemistry. 15:1941–1947.
  • Mori M, Aoyagi K, Tatibana M, Ishikawa T, Ishii H. 1977. N-δ-(phosphonacetyl)-L-ornithine, a potent transition-state analog inhibitor of ornithine carbamoyltransferase. Biochem Biophys Res Commun. 76:900–904.
  • Morris RP, Leeds JA, Naegeli HU, Oberer L, Memmert K, Weber E, LaMarche MJ, Parker CN, Burrer N, Esterow S, et al. 2009. Ribosomally synthesized thiopeptide antibiotics targeting elongation factor Tu. J Am Chem Soc. 131:5946–5955.
  • Morrow CA, Valkov E, Stamp A, Chow EW, Lee IR, Wronski A, Williams SJ, Hill JM, Djordjevic JT, Kappler U, et al. 2012. De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans. PLoS Pathog. 8:e1002957.
  • Murata S, Yashiroda H, Tanaka K. 2009. Molecular mechanisms of proteasome assembly. Nat Rev Mol Cell Biol. 10:104–115.
  • Nagaoka K, Matsumoto M, Oono J, Yokoi K, Ishizeki S, Nakashima T. 1986. Azinomycins A and B, new antitumor antibiotics. I. Producing organism, fermentation, isolation, and characterization. J Antibiot. 39:1527–1532.
  • Needham J, Kelly MT, Ishige M, Andersen RJ. 2002. Andrimid and moiramides A-C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas fluorescens: structure elucidation and biosynthesis. J Org Chem.
  • Newman DJ, Cragg GM. 2016. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 79:629–661.
  • Noda M, Matoba Y, Kumagai T, Sugiyama M. 2004. Structural evidence that alanine racemase from a D-cycloserine-producing microorganism exhibits resistance to its own product. J Biol Chem. 279:46153–46161.
  • Novikova M, Kazakov T, Vondenhoff GH, Semenova E, Rozenski J, Metlytskaya A, Zukher I, Tikhonov A, Van Aerschot A, Severinov K. 2010. MccE provides resistance to protein synthesis inhibitor microcin C by acetylating the processed form of the antibiotic. J Biol Chem. 285:12662–12669.
  • Novoa EM, Camacho N, Tor A, Wilkinson B, Moss S, Marín-García P, Azcárate IG, Bautista JM, Mirando AC, Francklyn CS, et al. 2014. Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo. Proc Natl Acad Sci U S A.
  • Oclarit JM, Okada H, Ohta S, Kaminura K, Yamaoka Y, Iizuka T, Miyashiro S, Ikegami S. 1994. Anti-bacillus substance in the marine sponge, Hyatella species, produced by an associated Vibrio species bacterium. Microbios. 78:7–16.
  • Ogawara H. 2015. Penicillin-binding proteins in Actinobacteria. J Antibiot. 68:223–245.
  • Olano C, Wilkinson B, Sanchez C, Moss SJ, Sheridan R, Math V, Weston AJ, Brana AF, Martin CJ, Oliynyk M, et al. 2004. Biosynthesis of the angiogenesis inhibitor borrelidin by Streptomyces parvulus Tu4055: cluster analysis and assignment of functions. Chem Biol. 11:87–97.
  • Olsthoorn-Tieleman LN, Palstra RJ, van Wezel GP, Bibb MJ, Pleij CW. 2007. Elongation factor Tu3 (EF-Tu3) from the kirromycin producer Streptomyces ramocissimus is resistant to three classes of EF-Tu-specific inhibitors. J Bacteriol. 189:3581–3590.
  • Paetz W, Nass G. 1973. Biochemical and immunological characterization of threonyl-transfer-rna synthetase of 2 borrelidin-resistant mutants of Escherichia coli K-12. Eur J Biochem. 35:331–337.
  • Panter F, Krug D, Baumann S, Müller R. 2018. Self-resistance guided genome mining uncovers new topoisomerase inhibitors from myxobacteria. Chem Sci. 9:4898–4908.
  • Paradkar AS, Aidoo KA, Wong A, Jensen SE. 1996. Molecular analysis of a beta-lactam resistance gene encoded within the cephamycin gene cluster of Streptomyces clavuligerus. J Bacteriol. 178:6266–6274.
  • Park JT, Uehara T. 2008. How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol Mol Biol Rev. 72:211–227.
  • Paulsen IT. 2003. Multidrug efflux pumps and resistance: regulation and evolution. Curr Opin Microbiol. 6:446–451.
  • Perez-Llarena F, Martin JF, Galleni M, Coque JJR, Fuente JL, Frere JM, Liras P. 1997. The bla gene of the cephamycin cluster of Streptomyces clavuligerus encodes a class A beta-lactamase of low enzymatic activity. J Bacteriol. 179:6035–6040.
  • Pestka S. 1974. Antibiotics as probes of ribosome structure: binding of chloramphenicol and erythromycin to polyribosomes; effect of other antibiotics. Antimicrob Agents Chemother. 5:255–267.
  • Pestka S, Brot N. 1971. Studies on the formation of transfer ribonucleic acid-ribosome complexes: XV. Effect of antibiotics on steps of bacterial protein synthesis: some new ribosomal inhibitors of translocation. J Biol Chem. 246:7715–7722.
  • Peterson Ryan M, Huang T, Rudolf Jeffrey D, Smanski Michael J, Shen B. 2014. Mechanisms of self-resistance in the platensimycin- and platencin-producing Streptomyces platensis MA7327 and MA7339 strains. Chem Biol. 21:389–397.
  • Pham JS, Dawson KL, Jackson KE, Lim EE, Pasaje CFA, Turner KEC, Ralph SA. 2014. Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites. Int J Parasitol Drugs Drug Resist. 4:1–13.
  • Piddock LJ. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev.19:382–402.
  • Poehlsgaard J, Douthwaite S. 2005. The bacterial ribosome as a target for antibiotics. Nat Rev Microbiol. 3:870–881.
  • Pojer F, Li SM, Heide L. 2002. Molecular cloning and sequence analysis of the clorobiocin biosynthetic gene cluster: new insights into the biosynthesis of aminocoumarin antibiotics. Microbiology. 148:3901–3911.
  • Pootoolal J, Neu J, Wright GD, 2002. Glycopeptide antibiotic resistance. In: Cho AK, Blaschke TF, Insel PA, et al., editors. Annual review of pharmacology and toxicology. p. 381–408.
  • Qiao M, Immonen T, Koponen O, Saris PE. 1995. The cellular location and effect on nisin immunity of the NisI protein from Lactococcus lactis N8 expressed in Escherichia coli and L. lactis. FEMS Microbiol Lett. 131:75–80.
  • Qin Z, Baker AT, Raab A, Huang S, Wang T, Yu Y, Jaspars M, Secombes CJ, Deng H. 2013. The fish pathogen Yersinia ruckeri produces holomycin and uses an RNA methyltransferase for self-resistance. J Biol Chem. 288:14688–14697.
  • Quiros LM, Carbajo RJ, Brana AF, Salas JA. 2000. Glycosylation of macrolide antibiotics. Purification and kinetic studies of a macrolide glycosyltransferase from Streptomyces antibioticus. J Biol Chem. 275:11713–11720.
  • Reader JS, Ordoukhanian PT, Kim JG, de Crecy-Lagard V, Hwang I, Farrand S, Schimmel P. 2005. Major biocontrol of plant tumors targets tRNA synthetase. Science. 309:1533.
  • Regueira TB, Kildegaard KR, Hansen BG, Mortensen UH, Hertweck C, Nielsen J. 2011. Molecular basis for mycophenolic acid biosynthesis in Penicillium brevicompactum. Appl Environ Microbiol. 77:3035–3043.
  • Reusser F. 1973. Rubradirin, a selective inhibitor of initiation factor dependent peptide-chain initiation. Biochemistry. 12:4524–4528.
  • Reusser F. 1983. Chapter 12, Rubradirin. In: Hahn FE, editor. Modes and mechanisms of microbial growth inhibitors. Berlin: Springer; p. 187–198.
  • Ross JI, Eady EA, Cove JH, Cunliffe WJ. 1998. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother. 42:1702–1705.
  • Russell AD. 2004. Whither triclosan? J Antimicrob Chemother. 53:693–695.
  • Salas JH, Méndez C, Olano C, Quirós LM, Rodríguez AM, Vilches C. 1994. Intracellular glycosylation and active efflux as mechanisms for resistance to oleandomycin in Streptomyces antibioticus, the producer organism. Microbiologia. 10:37–48.
  • Sanchez-Hidalgo M, Nunez LE, Mendez C, Salas JA. 2010. Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis. Antimicrob Agents Chemother. 54:1684–1692.
  • Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. 2008. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev. 32:234–258.
  • Schlunzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, Yonath A, Franceschi F. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature. 413:814–821.
  • Schmutz E, Muhlenweg A, Li SM, Heide L. 2003. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin. Antimicrob Agents Chemother. 47:869–877.
  • Schorn M, Zettler J, Noel JP, Dorrestein PC, Moore BS, Kaysser L. 2014. Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors. ACS Chem Biol. 9:301–309.
  • Sensi P, Margalith P, Timbal MT. 1959. Rifomycin, a new antibiotic; preliminary report. Farmaco Sci. 14:146–147.
  • Sepkowitz KA, Raffalli J, Riley L, Kiehn TE, Armstrong D. 1995. Tuberculosis in the AIDS era. Clin Microbiol Rev. 8:180–199.
  • Shen B, Du L, Sanchez C, Edwards DJ, Chen M, Murrell JM. 2002. Cloning and characterization of the bleomycin biosynthetic gene cluster from Streptomyces verticillus ATCC15003. J Nat Prod. 65:422–431.
  • Shiozawa H, Kagasaki T, Kinoshita T, Haruyama H, Domon H, Utsui Y, Kodama K, Takahashi S. 1993. Thiomarinol, a new hybrid antimicrobial antibiotic produced by a marine bacterium fermentation, isolation, structure, and antimicrobial activity. J Antibiot. 46:1834–1842.
  • Siegers K, Entian KD. 1995. Genes involved in immunity to the lantibiotic nisin produced by Lactococcus lactis 6F3. Appl Environ Microbiol. 61:1082–1089.
  • Singh S, Hager MH, Zhang C, Griffith BR, Lee MS, Hallenga K, Markley JL, Thorson JS. 2006. Structural insight into the self-sacrifice mechanism of enediyne resistance. ACS Chem Biol. 1:451–460.
  • Singh MP, Mroczenski-Wildey MJ, Steinberg DA, Andersen RJ, Maiese WM, Greenstein M. 1997. Biological activity and mechanistic studies of andrimid. J Antibiot. 50:270–273.
  • Slater SC, Goldman BS, Goodner B, Setubal JC, Farrand SK, Nester EW, Burr TJ, Banta L, Dickerman AW, Paulsen I, et al. 2009. Genome sequences of three agrobacterium biovars help elucidate the evolution of multichromosome genomes in bacteria. J Bacteriol. 191:2501–2511.
  • Smanski MJ, Yu Z, Casper J, Lin S, Peterson RM, Chen Y, Wendt-Pienkowski E, Rajski SR, Shen B. 2011. Dedicated ent-kaurene and ent-atiserene synthases for platensimycin and platencin biosynthesis. Proc Natl Acad Sci U S A. 108:13498–13503.
  • Sohng JK, Oh TJ, Lee JJ, Kim CG. 1997. Identification of a gene cluster of biosynthetic genes of rubradirin substructures in S. achromogenes var. rubradiris NRRL3061. Mol Cells. 7:674–681.
  • Speer BS, Salyers AA. 1989. Novel aerobic tetracycline resistance gene that chemically modifies tetracycline. J Bacteriol. 171:148–153.
  • Staskawicz BJ, Panopoulos NJ. 1979. Rapid and sensitive microbiological assay for phaseolotoxin. Phytopathology. 69:663–666.
  • Staskawicz BJ, Panopoulos NJ, Hoogenraad NJ. 1980. Phaseolotoxin-insensitive ornithine carbamoyltransferase of Pseudomonas syringae pv. phaseolicola: basis for immunity to phaseolotoxin. J Bacteriol. 142:720–723.
  • Steffensky M, Muhlenweg A, Wang ZX, Li SM, Heide L. 2000. Identification of the novobiocin biosynthetic gene cluster of Streptomyces spheroides NCIB 11891. Antimicrob Agents Chemother. 44:1214–1222.
  • Stegrnann E, Frasch HJ, Kilian R, Pozzi R. 2015. Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics. Int J Med Microbiol. 305:190–195.
  • Stukenberg PT, Studwell-Vaughan PS, O'Donnell M. 1991. Mechanism of the sliding beta-clamp of DNA polymerase III holoenzyme. J Biol Chem. 266:11328–11334.
  • Sugawara K, Hatori M, Nishiyama Y, Tomita K, Kamei H, Konishi M, Oki T. 1990. Eponemycin, a new antibiotic active against B16 melanoma.1. Production, isolation, structure and biological-activity. J Antibiot. 43:8–18.
  • Tang X, Li J, Millán-Aguiñaga N, Zhang JJ, O’Neill EC, Ugalde JA, Jensen PR, Mantovani SM, Moore BS. 2015. Identification of thiotetronic acid antibiotic biosynthetic pathways by target-directed genome mining. ACS Chem Biol. 10:2841–2849.
  • Templeton MD, Mitchell RE, Sullivan PA, Shepherd MG. 1985. The inactivation of ornithine transcarbamoylase by N delta-(N'-sulpho-diaminophosphinyl)-L-ornithine. Biochem J. 228:347–352.
  • Thiara AS, Cundliffe E. 1989. Interplay of novobiocin-resistant and -sensitive DNA gyrase activities in self-protection of the novobiocin producer, Streptomyces sphaeroides. Gene. 81:65–72.
  • Thompson J, Cundliffe E. 1980. Resistance to thiostrepton, siomycin, and sporangiomycin in actinomycetes that produce them. J Bacteriol. 142:455–461.
  • Thompson J, Schmidt F, Cundliffe E. 1982. Site of action of a ribosomal RNA methylase conferring resistance to thiostrepton. J Biol Chem. 257:7915–7917.
  • Tichenor MS, Kastrinsky DB, Boger DL. 2004. Total synthesis, structure revision, and absolute configuration of (+)-yatakemycin. J Am Chem Soc. 126:8396–8398.
  • Tocchetti A, Maffioli S, Iorio M, Alt S, Mazzei E, Brunati C, Sosio M, Donadio S. 2013. Capturing linear intermediates and C-terminal variants during maturation of the thiopeptide GE2270. Chem Biol. 20:1067–1077.
  • Toyohara M. 1987. Aspects of the antituberculous activity of 27753-RP, a new semisynthetic derivative of griselimycine. Ann Microbiol. 138:737–744.
  • Treede I, Jakobsen L, Kirpekar F, Vester B, Weitnauer G, Bechthold A, Douthwaite S. 2003. The avilamycin resistance determinants AviRa and AviRb methylate 23S rRNA at the guanosine 2535 base and the uridine 2479 ribose. Mol Microbiol. 49:309–318.
  • van Eijk E, Wittekoek B, Kuijper EJ, Smits WK. 2017. DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. J Antimicrob Chemother. 72:1275–1284.
  • van Wageningen AM, Kirkpatrick PN, Williams DH, Harris BR, Kershaw JK, Lennard NJ, Jones M, Jones SJ, Solenberg PJ. 1998. Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic. Chem Biol. 5:155–162.
  • Vázquez D, Kleinzeller A. 1979. Inhibitors of protein biosynthesis. Berlin: Springer. (Molecular biology, biochemistry and biophysics, vol. 30).
  • Vester B, Douthwaite S. 1994. Domain V of 23S rRNA contains all the structural elements necessary for recognition by the ErmE methyltransferase. J Bacteriol. 176:6999–7004.
  • Vetting MW, Hegde SS, Zhang Y, Blanchard JS. 2011. Pentapeptide-repeat proteins that act as topoisomerase poison resistance factors have a common dimer interface. Acta Crystallogr F Struct Biol Cryst Commun. 67:296–302.
  • Wakabayashi T, Kageyama R, Naruse N, Tsukahara N, Funahashi Y, Kitoh K, Watanabe Y. 1997. Borrelidin is an angiogenesis inhibitor: disruption of angiogenic capillary vessels in a rat aorta matrix culture model. J Antibiot. 50:671–676.
  • Wang ZX, Li SM, Heide L. 2000. Identification of the coumermycin A(1) biosynthetic gene cluster of Streptomyces rishiriensis DSM 40489. Antimicrob Agents Chemother. 44:3040–3048.
  • Wang S, Liu K, Xiao L, Yang L, Li H, Zhang F, Lei L, Li S, Feng X, Li A, et al. 2016. Characterization of a novel DNA glycosylase from S. sahachiroi involved in the reduction and repair of azinomycin B induced DNA damage. Nucleic Acids Res. 44:187–197.
  • Wang J, Soisson SM, Young K, Shoop W, Kodali S, Galgoci A, Painter R, Parthasarathy G, Tang YS, Cummings R, et al. 2006. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature. 441:358–361.
  • Wang J, Kodali S, Lee SH, Galgoci A, Painter R, Dorso K, Racine F, Motyl M, Hernandez L, Tinney E, et al. 2007. Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties. Proc Natl Acad Sci U S A. 104:7612–7616.
  • Ward JM, Hodgson JE. 1993. The biosynthetic genes for clavulanic acid and cephamycin production occur as a 'super-cluster' in three Streptomyces. FEMS Microbiol Lett. 110:239–242.
  • Wenzel SC, Hoffmann H, Zhang J, Debussche L, Haag-Richter S, Kurz M, Nardi F, Lukat P, Kochems I, Tietgen H, et al. 2015. Production of the bengamide class of marine natural products in myxobacteria: biosynthesis and structure-activity relationships. Angew Chem Int Ed Engl.
  • Whitwam RE, Ahlert J, Holman TR, Ruppen M, Thorson JS. 2000. The gene calC encodes for a non-heme iron metalloprotein responsible for calicheamicin self-resistance in Micromonospora. J Am Chem Soc. 122:1556–1557.
  • Wieland Brown LC, Acker MG, Clardy J, Walsh CT, Fischbach MA. 2009. Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin. Proic Natl Acad Sci U S A. 106:2549–2553.
  • Wietz M, Mansson M, Gotfredsen CH, Larsen TO, Gram L. 2010. Antibacterial compounds from marine Vibrionaceae isolated on a global expedition. Mar Drugs. 8:2946–2960.
  • Wietz M, Mansson M, Gram L. 2011. Chitin stimulates production of the antibiotic andrimid in a Vibrio coralliilyticus strain. Environ Microbiol Rep. 3:559–564.
  • Wilson DN. 2014. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat Rev Microbiol. 12:35–48.
  • Wolf H, Zahner H, Nierhaus K. 1972. Kirromycin, an inhibitor of the 30 S ribosomal subunits function. FEBS Lett. 21:347–350.
  • World Health Organization. 2010. Treatment of tuberculosis: guidelines. 4th ed. Geneva: World Health Organization.
  • Wright GD. 2011. Molecular mechanisms of antibiotic resistance. Chem Commun (Camb). 47:4055–4061.
  • Wu M, Singh SB, Wang J, Chung CC, Salituro G, Karanam BV, Lee SH, Powles M, Ellsworth KP, Lassman ME, et al. 2011. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc Natl Acad Sci U S A. 108:5378–5383.
  • Xu H, Huang W, He QL, Zhao ZX, Zhang F, Wang R, Kang J, Tang GL. 2012. Self-resistance to an antitumor antibiotic: a DNA glycosylase triggers the base-excision repair system in yatakemycin biosynthesis. Angew Chem Int Ed. 51:10532–10536.
  • Xue Y, Zhao L, Liu Hw, Sherman DH. 1998. A gene cluster for macrolide antibiotic biosynthesis in Streptomyces venezuelae: architecture of metabolic diversity. Proc Natl Acad Sci U S A. 95:12111–12116.
  • Yanagisawa T, Kawakami M. 2003. How does Pseudomonas fluorescens avoid suicide from its antibiotic pseudomonic acid?: evidence for two evolutionarily distinct isoleucyl-tRNA synthetases conferring self-defense. J Biol Chem. 278:25887–25894.
  • Yang Z, Funabashi M, Nonaka K, Hosobuchi M, Shibata T, Pahari P, Van Lanen SG. 2010. Functional and kinetic analysis of the phosphotransferase CapP conferring selective self-resistance to capuramycin antibiotics. J Biol Chem. 285:12899–12905.
  • Yeh HH, Ahuja M, Chiang YM, Oakley CE, Moore S, Yoon O, Hajovsky H, Bok JW, Keller NP, Wang CCC, et al. 2016. Resistance gene-guided genome mining: serial promoter exchanges in Aspergillus nidulans reveal the biosynthetic pathway for fellutamide B, a proteasome inhibitor. ACS Chem Biol. 11:2275–2284.
  • Yonath A. 2005. Antibiotics targeting ribosomes: resistance, selectivity, synergism, and cellular regulation. Annu Rev Biochem. 74:649–679.
  • Young TS, Walsh CT. 2011. Identification of the thiazolyl peptide GE37468 gene cluster from Streptomyces ATCC 55365 and heterologous expression in Streptomyces lividans. Proc Natl Acad Sci U S A. 108:13053–13058.
  • Zalacain M, Cundliffe E. 1989. Methylation of 23S rRNA caused by TlrA (ermSF), a tylosin resistance determinant from Streptomyces fradiae. J Bacteriol. 171:4254–4260.
  • Zalacain M, Cundliffe E. 1990. Methylation of 23S ribosomal RNA due to carB, an antibiotic-resistance determinant from the carbomycin producer, Streptomyces thermotolerans. Eur J Biochem. 189:67–72.
  • Zalacain M, Cundliffe E. 1991. Cloning of tlrD, a fourth resistance gene, from the tylosin producer, Streptomyces fradiae. Gene. 97:137–142.
  • Zeng Y, Kulkarni A, Yang Z, Patil PB, Zhou W, Chi X, Van Lanen S, Chen S. 2012. Biosynthesis of albomycin δ2 provides a template for assembling siderophore and aminoacyl-tRNA synthetase inhibitor conjugates. ACS Chem Biol. 7:1565–1575.
  • Zhao Q, He Q, Ding W, Tang M, Kang Q, Yu Y, Deng W, Zhang Q, Fang J, Tang G, et al. 2008. Characterization of the azinomycin B biosynthetic gene cluster revealing a different iterative type I polyketide synthase for naphthoate biosynthesis. Chem Biol. 15:693–705.
  • Zheng CJ, Sohn MJ, Lee S, Kim WG. 2013. Meleagrin, a new FabI inhibitor from Penicillium chryosogenum with at least one additional mode of action. PLoS One. 8:e78922.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.